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Abstract
Background: In patients with autosomal dominant polycystic kidney disease (ADPKD), malnutrition may develop as
renal function declines and the abdominal organs become enlarged. We investigated the relationship of intra-abdominal
mass with nutritional status.
Methods: This cross-sectional study was performed at a tertiary hospital outpatient clinic. Anthropometric and laboratory
data including serum creatinine, albumin, and cholesterol were collected, and kidney and liver volumes were measured.
Total kidney and liver volume was defined as the sum of the kidney and liver volumes and adjusted by height (htTKLV).
Nutritional status was evaluated by using modified subjective global assessment (SGA).
Results: In a total of 288 patients (47.9% female), the mean age was 48.3 ± 12.2 years and the mean estimated
glomerular filtration rate (eGFR) was 65.3 ± 25.3 mL/min/1.73 m2. Of these patients, 21 (7.3%) were mildly to
moderately malnourished (SGA score of 4 and 5) and 63 (21.7%) were at risk of malnutrition (SGA score of 6).
Overall, patients with or at risk of malnutrition were older, had a lower body mass index, lower hemoglobin levels,
and poorer renal function compared to the well-nourished group. However, statistically significant differences in these
parameters were not observed in female patients, except for eGFR. In contrast, a higher htTKLV correlated with a lower
SGA score, even in subjects with an eGFR ≥45 mL/min/1.73 m2. Subjects with an htTKLV ≥2340 mL/m showed an
8.7-fold higher risk of malnutrition, after adjusting for age, hemoglobin, and eGFR.
Conclusions: Nutritional risk was detected in 30% of ambulatory ADPKD patients with relatively good renal function.
Intra-abdominal organomegaly was related to nutritional status independently from renal function deterioration.
Keywords: Autosomal-dominant polycystic kidney disease, Chronic kidney disease, Gender, Malnutrition, Polycystic
liver disease
Background
Malnutrition increases mortality, morbidity, and the
duration of the hospital stay in various clinical settings,
including inpatient settings in general as well as in liver
failure and cancer patients [1]. In chronic kidney dis-
ease (CKD), the prevalence of malnutrition increases to
30–40% of patients, and protein-energy malnutrition is
one of the strongest predictors of morbidity and mor-
tality [2, 3]. In previous studies, nutritional markers
such as serum albumin, creatinine, body mass index
(BMI), and subjective global assessment (SGA) score
were independent predictors of death and treatment
failure in CKD [4, 5]. Pre-transplant nutritional status
also influences the outcomes of kidney transplantations
[6]. Therefore, efforts have been made to establish
guidelines for properly assessing the nutritional status
of CKD patients and intervening to improve their
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outcomes [7]. However, the value of nutritional markers
in the early stage of CKD was not meticulously evalu-
ated in patients with early stages of CKD.
Autosomal dominant polycystic kidney disease (ADPKD)
is the most common hereditary kidney disease, and can
progress to end-stage renal disease (ESRD) as kidney cysts
grow. The prevalence of liver cysts in ADPKD patients was
58% in patients aged 15–24 years and up to 94% of patients
older than 35 years [8]. Many uncontainable complications
can develop as cysts grow to cause massive organomegaly.
From previous study, mass effect due to organomegaly was
reported to cause pressure related symptoms (46.5%), pain
(58.8%), gastrointestinal symptoms (32.4%) and obstructive
complications which can lead to leg edema (20.4%), ascites
(16.6%) and infection (3.1%) [9]. In these patients, pressure
effects from the enlarged organs may also result in poor
oral intake and eventually malnutrition. Occasionally,
massive organomegaly requires volume reduction interven-
tions to relieve symptoms and to improve the patient’s
quality of life [10].
In ADPKD, the mass effects from increased kidney
and liver volume may aggravate malnutrition, even in
the early stages of kidney disease [11]. Therefore,
assessment of nutritional status even in the early stages
of ADPKD with significant organomegaly is advised to
ensure timely interventions that result in the subse-
quent improvement of clinical outcomes as in polycys-
tic liver disease patients [11, 12]. However, traditional
anthropometric parameters, such as body weight and
BMI, are of limited value because of the fluid-filled
kidneys and liver. In this study, we evaluated the nu-
tritional status of ambulatory ADPKD patients using
SGA as a standard method, and identified intra-




ADPKD patients who visited polycystic kidney disease
clinic in Seoul National University Hospital from
December 2013 to March 2014 were included in this
study. Patients of age 18 years and older who agreed to
participate in the study were included. Abdominal com-
puted tomography (CT) scan on ADPKD patients were
taken every other year for clinical purpose as a standard-
ized evaluation protocol during the outpatient clinic
[13]. Patients with active cancer, active infection, CKD
stage 5 at the time of enrollment, ESRD treated with
renal replacement therapy, or a history of volume-
reductive therapies of liver (transarterial embolization,
liver resection or transplantation) due to severe polycys-
tic liver disease were excluded. Electronic medical re-
cords were reviewed retrospectively and 31 patients
were identified who met exclusion criteria.
Since this study was a cross-sectional one using clin-
ical data, and it did not involve further invasive inter-
vention, treatment, or costs to patients, the study
received a consent exemption and it was approved by
the Institutional Review Board of Seoul National
University Hospital (H-1407-083-594). The patient’s
record was de-identified and analyzed anonymously.
This study was performed in accordance with the
Declaration of Helsinki.
Subjective global assessment and clinical data collection
The SGA score is a method of nutritional assessment
that has been well validated in various settings and is
based on a clinical history and physical examination.
Nutritional assessment has been validated in CKD pa-
tients as a predictor of complications and outcomes
[10–13]. Based on these results, SGA has been recom-
mended in the Kidney Disease Outcomes Quality
Initiative guidelines as a nutritional assessment tool,
especially for CKD patients [7]. SGA is frequently used
as a reference method for evaluating new nutritional
assessment techniques.
The modified SGA, which has been validated in many
studies of CKD patients [14–17], was performed to
evaluate the nutritional status of ADPKD patients ac-
cording to the standardized protocol in our clinic from
December 2013. A well-trained internist performed SGA
to ensure consistency. SGA consists of a medical history
(weight changes, dietary intake, gastrointestinal symp-
toms, functional capacity, and comorbidities related to
nutritional needs) and a physical examination. In detail,
a clinician inspected subcutaneous fat below the eye, tri-
ceps or biceps area or at chest area, and examined the
temples, clavicles and the back of the hands for muscle
wasting. The presence of edema or ascites was assessed
by physical examination. Based on these components, a
clinician uses a seven-point scale to reflect an overall
judgment of the patient’s nutritional status. The SGA
score was interpreted as follows: 7, well nourished; 6, at
risk; 5, mildly malnourished; 3–4, moderately mal-
nourished; and 1–2, extremely malnourished. Labora-
tory tests, including serum hemoglobin, creatinine,
total protein, albumin, and total cholesterol were sim-
ultaneously performed. Estimated glomerular filtration
rates (eGFR) were calculated by the Chronic Kidney
Disease Epidemiology equation, using isotope dilution
mass spectrometry-traceable creatinine [18].
Volume measurement of kidneys and liver
In our polycystic kidney disease clinic, abdominal CT
scans were taken every other year. A latest abdominal
CT scan at the time of nutritional assessment was used
to measure total liver volume (TLV) and total kidney
volume (TKV). The mean time interval between the CT
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scan and the nutritional assessment was 12.5 ±
12.6 months. TLV was calculated by adding the product
of slice thickness and the area measured on a set of con-
tiguous images generated by CT using Rapidia 2.8 CT
software (INFINITT Healthcare Co. Ltd, Seoul, Korea).
TKV was estimated by using the ellipsoid method [19].
Height-adjusted TLV (htTLV, mL/m) and height-
adjusted TKV (htTKV, mL/m) were used in this study.
Height-adjusted total kidney and liver volume (htTKLV,
mL/m) was defined as the sum of the htTLV and
htTKV values.
Statistical analyses
For statistical analysis between genders, we used student
t-test for variables with a normal distribution and used
Mann-Whitney test for variables with a non-normal
distribution (height, weight, protein, albumin, htTLV,
htTKV, and htTKLV). For SGA scores, all patients were
classified into three groups: mildly to moderately mal-
nourished (an SGA score of 4–5), at risk (an SGA score
of 6), and well nourished (an SGA score of 7), because
none had SGA score less than 4 [20]. For statistical
analysis, we used linear association test or Jonckheere-
Terpstra test to analyze the p-for trend among three
SGA groups. P-values <0.05 were considered to indicate
statistical significance.
Receiver operating characteristic (ROC) curve analysis
was used to evaluate htTKLV as a discriminating param-
eter for malnutrition (SGA score ≤5), in contrast with
the well-nourished group (score 7). In this analysis we
excluded patients with SGA score of 6 to analysis the
effect of htTKLV on definite malnutrition. The Youden
index was used to determine the optimal cutoff value.
Binominal logistic regression was used to test the signifi-
cance of the htTKLV threshold after adjusting for age,
hemoglobin, and eGFR. All statistical analyses were con-
ducted using SPSS version 22 (IBM Corporation,
Armonk, NY, USA) and MedCalc for Windows version
14 (MedCalc Software, Ostend, Belgium).
Results
Baseline characteristics
A total of 288 patients were included in the analysis, of
whom 138 (47.9%) were female. The mean age was 48.3
± 12.2 years, with no significant difference according to
gender. The mean SGA scores were similar (6.7 ± 0.6 vs.
6.6 ± 0.6, p = 0.197) between genders. The mean eGFR
were 65.3 ± 25.3 mL/min/1.73 m2 and eGFR was higher
in female patients (62.3 ± 24.5 mL/min/1.73 m2 vs. 68.5
± 25.8 mL/min/1.73 m2, p = 0.035). There was no signifi-
cant difference in albumin level between genders. The
distribution of CKD stages was as follows: 52 patients
(18.1%) were in stage 1 CKD, 116 (40.3%) were in stage
2, 53 (18.4%) were in stage 3A, 46 (16.0%) were in stage
3B, and 21 (7.3%) were in stage 4. The distribution of
CKD showed no difference between genders. Two hun-
dred thirty-eight patients (82.6%) had hypertension and
227 patients (78.8%) had liver cysts. Male had higher
prevalence of hypertension (male; 134 patients, 89.3%
and female; 104 patients, 75.4%, p = 0.002) and lower
prevalence of liver cysts. (male; 101 patients, 67.3% and
female 126 patients, 91.3%, p < 0.001). Also in order to
evaluate the mass effect of kidney and liver volume on
nutritional status, TKV and TLV were measured using
CT scans and adjusted for height. Overall, the median
htTKLV was 1776 mL/m with interquartile range (IQR)
1361–2381 mL/m, the median htTKV was 697 mL/m
(IQR 415–1133 mL/m), and the median htTLV was
977 mL/m (IQR 819–1196 mL/m). There were no sig-
nificant difference between genders in htTKLV, htTKV
and htTLV. With height unadjusted volume, TKLV and
TLV did not showed statistical difference between gen-
ders (p = 0.076 and p.0.255 respectively). Only TKV
showed difference between gender (p = 0.003), however
the difference disappeared after adjusting with height
(p = 0.057) (Additional file 1: Table S1).
Nutritional status of subjects
Mild to moderate malnutrition was detected in 7.3% of
all patients. Only two patients (0.7%) had an SGA score
of 4, and 19 patients (6.6%) had a score of 5. Sixty-three
patients (21.9%) were at risk of malnutrition (a score of
6), and 204 (70.8%) were well nourished (a score of 7).
No statistical difference was observed in the distribution
of SGA scores between genders (Table 1).
Patients with malnutrition (SGA 4–5) or at risk for
malnutrition (SGA 6) were older than the well-
nourished group (SGA 7) (mean age, 53.4 ± 11.1 years
vs. 52.7 ± 12.6 years vs. 46.4 ± 11.7 years, respectively,
p for trend <0.001). In terms of anthropometric pa-
rameters, weight (59.1 ± 8.7 kg vs. 62.3 ± 9.7 kg vs.
67.0 ± 12.3 kg, respectively, p for trend 0.001) and BMI
(22.0 ± 2.7 kg/m2 vs. 23.3 ± 2.6 kg/m2 vs. 23.7 ± 2.9 kg/m2,
respectively, p for trend 0.044) tended to show lower
values in patients with lower SGA scores. However, this
trend was observed only in male patients, and none of the
anthropometric parameters showed statistically significant
differences in female patients (Fig. 1).
With regard to laboratory parameters, decreased
eGFR values (51.3 ± 23.2 mL/min/1.73 m2 vs. 57.1 ±
24.9 mL/min/1.73 m2 vs. 69.2 ± 24.6 mL/min/1.73 m2,
respectively, p for trend <0.001) were related to lower
SGA scores. Hemoglobin (12.8 ± 1.1 g/dL vs. 13.2 ±
1.4 g/dL vs. 13.7 ± 1.5 g/dL, respectively, p for trend
<0.001) also showed differences according to SGA
scores. This trend was seen only in male patients, but
not in female patients. Serum total cholesterol, total
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protein, and albumin levels showed no statistically sig-
nificant differences by SGA score (Table 1, Fig. 2).
Hypertension showed higher prevalence in lower SGA
groups (100, 87.3 and 79.4% respectively, p for trend =
0.011). However there was no statistical difference in liver
cyst prevalence among SGA groups (p for trend = 0.16)
(Table 1).
When we compared various data between SGA score of
4 and 5 (malnutrition) with 6 and 7 (at risk or well nour-
ished), similar results were obtained (Additional file 1:
Table S2).
htTKLV was associated with SGA independently
from eGFR
Lower SGA scores corresponded to higher values of
htTKLV (median 2622 mL/m; IQR 1719–4906 mL/m vs.
median 2147 mL/m; IQR 1535–2687 mL/m vs. median
1649 mL/m; IQR 1311–2151 mL/m, respectively, p for
trend <0.001), htTKV (median 1282 mL/m; IQR 524–
1574 mL/m vs. median 903 mL/m; IQR 559–1246 mL/m
vs. median 640 mL/m; IQR 394–955 mL/m, respectively,
p for trend <0.001), and htTLV (median 1298 mL/m; IQR
830–2831 mL/m vs. median 1023 mL/m; IQR 816–
1322 mL/m vs. median 957 mL/m; IQR 819–1147 mL/m,
respectively, p for trend =0.036) (Table 1, Fig. 3).
ROC curve analysis was used to compare the volume
parameters to identify a threshold predictive of malnu-
trition (an SGA of 4–5) over a state of being well nour-
ished (an SGA score of 7). Since SGA score category 6
can be ambiguous due to the limitations of SGA itself,
we constructed the ROC curve using the data of SGA
score 7 (normal) and 4–5 (malnutrition). The area under
the curve (AUC) of htTKLV was larger (0.727) than that
of htTKV (0.687) and htTLV (0.645). The cut-off value
for htTKLV was 2340 mL/m, with a sensitivity of 66.7%
and a specificity of 81.4% (Fig. 4). By comparison, in an
ROC curve analysis between an at-risk or malnourished
state over a well-nourished state (an SGA of 4–6 vs. 7),
similar but less significant results were obtained (AUC
of htTKLV, htTKV, and htTLV were 0.658, 0.646, and
0.571, respectively), and the cut-off value for htTKLV
was 2190 mL/m with a sensitivity of 53.6% and a specifi-
city of 76.5% (data not shown).
It is well known that the enlargement of the kidneys is
closely related to renal insufficiency in ADPKD patients
[21]. As expected, the eGFR fell as the SGA score de-
creased (Fig. 2), and the proportion of patients with
lower SGA scores increased in our patients as the CKD
stages increased from 1 to 3 (Fig. 5). When we stratified
by CKD stage, even in stage 1 and 2 CKD, 15.4 and
Table 1 Baseline patient characteristics according to nutritional status as evaluated by SGA
Parameters Mildly to moderately malnourished
(SGA 4 and 5)
At risk
(SGA 6)
Well nourished (SGA 7) P for trend
Number of patients 21 (7.3%) 63 (21.9%) 204 (70.8%)
Female 9 (42.9%) 37 (58.7%) 92 (45.1%) 0.148
Age (years) 53.4 ± 11.1 52.7 ± 12.6 46.4 ± 11.7 <0.001
Height (cm) 164.0 ± 7.9 163.4 ± 7.9 167.6 ± 9.8 0.002
Weight (kg) 59.1 ± 8.7 62.3 ± 9.7 67.0 ± 12.3 0.001
BMI (kg/m2) 22.0 ± 2.7 23.3 ± 2.6 23.7 ± 2.9 0.044
Hemoglobin (g/dL) 12.8 ± 1.1 13.2 ± 1.4 13.7 ± 1.5 <0.001
eGFR (mL/min/1.73 m2) 51.3 ± 23.2 57.1 ± 24.9 69.2 ± 24.6 <0.001
Protein (g/dL) 7.4 ± 0.4 7.2 ± 0.4 7.3 ± 0.4 0.328
Albumin (g/dL) 4.4 ± 0.3 4.3 ± 0.3 4.4 ± 0.4 0.377
Total cholesterol (mg/dL) 180.3 ± 30.2 175.8 ± 27.7 177.4 ± 26.0 0.654
Presence of hypertension 21 (100%) 55 (87.3%) 162 (79.4%) 0.011
Presence of liver cysts 17 (81%) 55 (87.3%) 155 (76.0%) 0.160
TKLV (mL) 4,581 [2,698–7,899] 3,445 [2,642–4,415] 2,808 [2,241–3,695] <0.001
TKV (mL) 2,089 [817–2,801] 1,443 [913–2,070] 1,059 [638–1,628] <0.001
TLV (mL) 2,039 [1,336–4,728] 1,659 [1,352–2,200] 1,636 [1,337–1,951] 0.120
htTKLV (mL/m) 2,622 [1,719–4,906] 2,147 [1,535–2,687] 1,649 [1,311–2,151] <0.001
htTKV (mL/m) 1,282 [524–1,574] 903 [559–1,246] 640 [394–955] <0.001
htTLV (mL/m) 1,298 [830–2,831] 1,023 [816–1,322] 957 [819–1,147] 0.036
TKLV, TKV, TLV, htTKLV, htTKV and htTLV are shown in median and interquartile range
BMI body mass index, CKD chronic kidney disease, eGFR estimated glomerular filtration rates, htTKV height-adjusted total kidney volume, htTKLV height-adjusted
total kidney and liver volume, htTLV height-adjusted total liver volume, SGA subjective global assessment, TKV total kidney volume, TKLV total kidney and liver
volume, TLV total liver volume
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20.9% of patients were either malnourished or at risk of
malnutrition, respectively. Among stage 3 and 4 CKD
patients, 43.4 and 42.8% were either malnourished or at
risk of malnutrition, respectively. In patients with stage
4 CKD, the proportion of patients with a lower SGA
score was slightly lower than among stage 3B CKD pa-
tients, which may have been due to the relatively small
number of patients in stage 4 CKD or because we ex-
cluded patients with severe organomegaly who had
already undergone surgical intervention.
In order to minimize the confounding effect of renal
failure, subgroup analysis was performed in patients with
an eGFR ≥45 mL/min/1.73 m2 (CKD stages 1–3A). In
these patients, only htTKLV showed a significant associ-
ation with SGA scores (Fig. 3d).
Using 2340 mL/m as the cut-off value of htTKLV
based on ROC curve analysis, logistic regression ana-
lysis was used to estimate the odds ratio between the
malnourished (an SGA score of 4–5) and the well-
nourished group (an SGA score of 7) using variables
that showed statistical significance among SGA groups.
Patients with htTKLV ≥2340 mL/m showed a higher risk
of malnutrition (an SGA score of 4–5) (odds ratio = 8.74,
95% confidence interval 3.30–23.13, p < 0.001), even after
adjusting for age, hemoglobin, and eGFR.
Discussion
Although previous studies have assessed the association
of htTKV with renal function outcomes [22] and poor
quality of life [23], this is the first study to assess the nu-
tritional status of ADPKD patients and its relationship
with htTKLV. In our previous study, an htTLV value
>1600 mL/m was associated with an increase in pressure
symptoms [9]. Therefore, we hypothesized that an en-
larged liver and/or kidneys may exert a mass effect on
the nearby areas of the gastrointestinal tract, causing
gastrointestinal symptoms and eventually affecting the
nutritional status of ADPKD patients. With this in mind,
we measured htTKV and htTKLV, defining htTKLV to
reflect the total mass effect of the enlarged kidneys and
liver. We showed that htTKLV was the sole significant
predictor of malnutrition after adjusting for other risk
factors, including renal function. Even in subjects with
relatively good renal function (eGFR ≥45 mL/min/
1.73 m2), htTKLV was significantly associated with SGA
scores of 4 and 5. Based on the ROC curve analysis and
binominal logistic regression, htTKLV values ≥2340 mL/m,
which is three times larger than the mean liver volume of
healthy individuals [24], raised the risk of malnutrition by
more than eightfold in ADPKD patients. When compared
with htTLV and htTKV, htTKLV showed a closer
Fig. 1 Correlations between the SGA score and the anthropometric nutritional parameters. a body weight (Bwt) and b body mass index
(BMI). P*; p for trend, SGA; subjective global assessment, SGA 7, well-nourished; SGA 6, at risk; SGA 5, mildly malnourished; SGA 3–4,
moderately malnourished
Ryu et al. BMC Nephrology  (2017) 18:22 Page 5 of 10
relationship to malnutrition on the ROC curve, sug-
gesting that total organ volume, instead of the size of
each organ, may be responsible for the mass effect and
the corresponding symptoms. However, since we ex-
cluded patients with severe polycystic liver disease who
underwent surgical therapy (n = 16; mean htTLV, 5136
± 2563 mL/m), the statistical association of htTLV with
SGA scores could have been underestimated.
This study also shows that the prevalence of malnutri-
tion in ADPKD should not be ignored. Most of patients
had no malnutiriton (70.8%). However, even in out-
patient clinic, 7.3% of patients were mildly to moderately
malnourished (SGA scores of 4 and 5), and 21.9% of pa-
tients were at risk of malnutrition (an SGA score of 6).
From previous studies, the prevalence of malnutrition
in stage 4 and 5 CKD has been reported to be 20–30%
Fig. 2 Correlations between the SGA score and the following laboratory markers. a estimated glomerular filtration rate (eGFR), b hemoglobin
(Hb), c albumin, and d total cholesterol (total chol). P*; p for trend, SGA; subjective global assessment, SGA 7, well-nourished; SGA 6, at risk; SGA 5,
mildly malnourished; SGA 3–4, moderately malnourished
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[16, 25], and 10–60% of dialyzed patients have been
found to have malnutrition (SGA score ≤ B by using
conventional SGA or ≤5 by using modified SGA) [26].
Cuppari et al. [20] found that approximately 11% of pa-
tients with stage 2–5 CKD had protein-energy wasting
(SGA ≤5) and 32% showed signs of protein-energy
wasting (SGA 6). It is not proper to compare our data
with those of Cuppari et al. [20], since most partici-
pants in their study were in the advanced stages of
CKD (48.9% in stage 3 and 40.3% in stage 4), unlike our
patient sample (58% in stage 1–2 CKD) (Fig. 5). More-
over, it is surprising that the prevalence of malnutrition
Fig. 3 Correlations between the SGA score and abdominal volume. a height-adjusted total kidney and liver volume (htTKLV), b height-adjusted
total kidney volume (htTKV), and c height-adjusted total liver volume (htTLV); d correlation between SGA score and abdominal volume in subjects
with an eGFR ≥45 mL/min/1.73 m2. P*; p for trend, SGA; subjective global assessment, SGA 7, well-nourished; SGA 6, at risk; SGA 5, mildly
malnourished; SGA 3–4, moderately malnourished
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risk (SGA ≤6) is up to 30% in patients treated in an am-
bulatory setting with relatively good renal function. We
further analyzed whether these findings in ADPKD
could be due to the increased volume of the kidneys
and liver, which can cause various gastrointestinal
symptoms and malnutrition even in the early stages of
CKD. In our study, SGA score correlated with htTKLV
even in the patients with relatively well preserved
kidney function (eGFR ≥45 mL/min/1.73 m2 or CKD
stages 1–3A).
Renal insufficiency itself can contribute to malnutri-
tion and protein-energy wasting [27]. We also observed
increased proportions of patients with malnutrition as
the CKD stage advanced. The proportion of patients
with a lower SGA score was slightly lower in stage 4
CKD than stage 3B patients, which may have been due
to the relatively small number of patients in stage 4
CKD or because we excluded patients with severe orga-
nomegaly who had already undergone surgical interven-
tion. In addition, when we analyzed parameters with
SGA scores, most anthropometric or laboratory parame-
ters that are widely used as markers for nutritional status
failed to show an association with SGA scores, except
for renal function. This finding that renal function was
significantly related to SGA scores suggests regular as-
sessment of nutritional status in ADPKD patients is
needed as the disease progresses.
The association of parameters with SGA scores was
different between genders. In male patients, old age,
lower body weight, lower BMI, and lower hemoglobin
levels were related to lower SGA scores, but these rela-
tionships were not seen in female patients. One of ex-
planation would be the relatively less muscle mass in
women compared to men, changes in body weight and
BMI caused by malnutrition might be too small to be
detected in our Asian women population. Moreover, en-
larged cysts, ascites, or edema, which are frequent com-
plications in ADPKD patients, may mask the reduction
in muscle mass or fat proportion in the body. Laboratory
parameters such as hemoglobin, total protein, albumin,
or total cholesterol were not sensitive enough to detect
changes in nutritional status during the early stages of
malnutrition. Thus, further studies will be needed to
confirm this finding in other cohorts and clarify the rea-
son including analyzing muscle mass. Also other
markers for nutritional status should be developed for
patients with ADPKD, especially for female ADPKD
patients.
In this study, we found that 23.5% of patients had nu-
tritional problem (SGA score ≤6) even in early stage
CKD (stage 1-3a). In addition, increased htTKLV was
an independent risk factor after adjusting for kidney
function by using a multivariate logistic regression
model. Other nutritional biomarkers, such as prealbu-
min, insulin-like growth factor-1, or transferrin, were
not assessed in this study. htTKLV could provide valu-
able information about nutritional status as well as the
progression of disease, but it is cumbersome to meas-
ure with current methods. Therefore, developing new
tools for the nutritional assessment of ADPKD patients
is necessary, and such tools would be useful for im-
proving long-term patient outcomes.
Even though this is the first observational study show-
ing the impact of abdominal mass on nutritional status
in ADPKD, it has several limitations. Relatively small
numbers of patients in the low-SGA group may have
undermined the statistical power, especially in females.
Moreover, our hypothesis that the mass effect from en-
larged liver and kidneys may be related to nutrition
needs to be further verified by comparing with other
Fig. 4 ROC curve of htTKLV, comparing SGA scores of 4 and 5 to 7.
ROC; receiver-operating characteristics, SGA; subjective global
assessment, SGA 7, well-nourished; SGA 6, at risk; SGA 5, mildly
malnourished; SGA 3–4, moderately malnourished
Fig. 5 SGA score distribution according to CKD stages. P-values
were obtained using the Fisher’s exact test. Bars indicate the
percentage of patients in each category. CKD; chronic kidney
disease, SGA; subjective global assessment
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non-ADPKD CKD groups, which is not possible for
now because of lack of data on nutritional status in
the early CKD stages. Also further comprehensive
studies are needed to understand the factors affecting
nutritional status in ADPKD patients including socio-
economic state and detailed food intake using diary.
Although SGA is a well-validated method for nutri-
tional assessment in patients with a range of condi-
tions and is easy to perform, its ability to detect
subtle changes in long-term nutritional status needs
to be validated. Therefore, this study should be repli-
cated in other larger cohorts, preferably in the form
of a multicenter design including non-Asian popula-
tions. Also to improve the patients outcome eventu-
ally, more studies are needed to find out the possible
effective therapies such as nutritional counseling and
diet intervention to prevent and treat the malnutri-
tion in ADPKD patients. This is a cross-sectional
study but there are time interval between SGA meas-
urement and CT scan as 12.5 ± 12.6 months. We used
routinely perform CT scan to measure TKV, TLV and
TKLV which are taken every other year in ADPKD
outpatient clinic. Since the annual growth of PLD is
about 0.9 to 3.2% we thought it was acceptable to
use the information from the latest regular follow up CT
image instead of taking new one at the time of nutritional
assessment [28]. Because of this limitation, there were 4
patients who had renal aspiration and sclerotherapy be-
tween CT scan and SGA assessment. However when we
analyzed data after excluding 4 patients, the similar result
was seen and we reported whole patient’s data.
Conclusions
In conclusion, detecting marginal malnutrition in pa-
tients in ADPKD outpatient clinics and initiating proper
support can play an important therapeutic role, espe-
cially in patients who have decreased renal function or
an increased htTKLV.
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